Record Information |
---|
Version | 2.0 |
---|
Created at | 2023-01-14 16:03:17 UTC |
---|
Updated at | 2024-09-03 04:15:45 UTC |
---|
NP-MRD ID | NP0331440 |
---|
Natural Product DOI | https://doi.org/10.57994/0389 |
---|
Secondary Accession Numbers | |
---|
Natural Product Identification |
---|
Common Name | Trans-resveratrol |
---|
Description | Resveratrol, also known as trans-resveratrol, belongs to the class of organic compounds known as stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. Thus, resveratrol is considered to be an aromatic polyketide. Resveratrol exists in all living species, ranging from bacteria to plants to humans. Resveratrol is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Trans-resveratrol was first documented in 2021 (PMID: 34606154). Based on a literature review a significant number of articles have been published on Resveratrol (PMID: 34598655) (PMID: 34597721) (PMID: 34597611) (PMID: 34594318) (PMID: 36603655). |
---|
Structure | OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1 InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+ |
---|
Synonyms | Value | Source |
---|
(e)-5-(2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol | ChEBI | (e)-Resveratrol | ChEBI | 3,4',5-Stilbenetriol | ChEBI | 3,4',5-Trihydroxy-trans-stilbene | ChEBI | 3,4',5-Trihydroxystilbene | ChEBI | 3,5,4'-Trihydroxystilbene | ChEBI | 5-[(e)-2-(4-Hydroxyphenyl)vinyl]benzene-1,3-diol | ChEBI | trans-Resveratrol | Kegg | trans-3,4',5 - Trihydroxystilbene | HMDB | SRT 501 | MeSH, HMDB | SRT-501 | MeSH, HMDB | trans Resveratrol | MeSH, HMDB | (E)-2-(3,5-Dihydroxyphenyl)-1-(4-hydroxyphenyl)ethene | HMDB | (E)-3,4',5-Trihydroxystilbene | HMDB | (E)-3,4’,5-Trihydroxystilbene | HMDB | (E)-5-(p-Hydroxystyryl)resorcinol | HMDB | 3,4’,5-Stilbenetriol | HMDB | 3,4’,5-Trihydroxy-trans-stilbene | HMDB | 3,4’,5-Trihydroxystilbene | HMDB | 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol | HMDB | Resveratrol | HMDB | trans-3,5,4'-Trihydroxystilbene | HMDB | trans-3,5,4’-Trihydroxystilbene | HMDB | (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol | PhytoBank |
|
---|
Chemical Formula | C14H12O3 |
---|
Average Mass | 228.2470 Da |
---|
Monoisotopic Mass | 228.07864 Da |
---|
IUPAC Name | 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol |
---|
Traditional Name | resveratrol |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC1=CC=C(\C=C\C2=CC(O)=CC(O)=C2)C=C1 |
---|
InChI Identifier | InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+ |
---|
InChI Key | LUKBXSAWLPMMSZ-OWOJBTEDSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
HSQC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-02-02 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-02-02 | View Spectrum | HMBC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-02-02 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-02-02 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-02-02 | View Spectrum | HMBC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | john.cort@pnnl.gov | Not Available | Not Available | 2023-06-14 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | john.cort@pnnl.gov | Not Available | Not Available | 2023-06-14 | View Spectrum | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | john.cort@pnnl.gov | Not Available | Not Available | 2023-06-14 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | john.cort@pnnl.gov | Not Available | Not Available | 2023-06-14 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | john.cort@pnnl.gov | Not Available | Not Available | 2023-06-14 | View Spectrum | ROESY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | lpecio@iung.pulawy.pl | Not Available | Not Available | 2023-01-14 | View Spectrum | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | lpecio@iung.pulawy.pl | Not Available | Not Available | 2023-01-14 | View Spectrum | HMBC NMR | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | lpecio@iung.pulawy.pl | Not Available | Not Available | 2023-01-14 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | lpecio@iung.pulawy.pl | Not Available | Not Available | 2023-01-14 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | lpecio@iung.pulawy.pl | Not Available | Not Available | 2023-01-14 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | lpecio@iung.pulawy.pl | Not Available | Not Available | 2023-01-14 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400Mz MHz, DMSO, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
| Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 500.2, CD3OD, simulated) | lpecio@iung.pulawy.pl | Not Available | Not Available | 2024-05-11 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400Mz, DMSO, simulated) | rgf8b@missouri.edu | Not Available | Not Available | 2020-10-06 | View Spectrum |
| Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
schidigera | | |
|
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Stilbenes |
---|
Sub Class | Not Available |
---|
Direct Parent | Stilbenes |
---|
Alternative Parents | Not Available |
---|
Substituents | Not Available |
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Tarallo A, Damiano C, Strollo S, Minopoli N, Indrieri A, Polishchuk E, Zappa F, Nusco E, Fecarotta S, Porto C, Coletta M, Iacono R, Moracci M, Polishchuk R, Medina DL, Imbimbo P, Monti DM, De Matteis MA, Parenti G: Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease. EMBO Mol Med. 2021 Nov 8;13(11):e14434. doi: 10.15252/emmm.202114434. Epub 2021 Oct 4. [PubMed:34606154 ]
- Wang Z, Li L, Gu W, Mao Y, Wang T: Resveratrol Reverses Osteogenic Decline of Bone Marrow Mesenchymal Stem Cells Via Upregulation of YAP Expression in Inflammatory Environment. Stem Cells Dev. 2021 Dec 15;30(24):1202-1214. doi: 10.1089/scd.2021.0195. Epub 2021 Oct 27. [PubMed:34598655 ]
- Huang Y, Zhang J, Tao Y, Ji C, Aniagu S, Jiang Y, Chen T: AHR/ROS-mediated mitochondria apoptosis contributes to benzo[a]pyrene-induced heart defects and the protective effects of resveratrol. Toxicology. 2021 Oct;462:152965. doi: 10.1016/j.tox.2021.152965. Epub 2021 Sep 28. [PubMed:34597721 ]
- Chhabra G, Singh CK, Guzman-Perez G, Ndiaye MA, Iczkowski KA, Ahmad N: Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in Braf(V600E)/Pten(NULL) Mice. J Invest Dermatol. 2022 Apr;142(4):1145-1157.e7. doi: 10.1016/j.jid.2021.08.434. Epub 2021 Sep 29. [PubMed:34597611 ]
- Santos CA, Lima EMF, Franco BDGM, Pinto UM: Exploring Phenolic Compounds as Quorum Sensing Inhibitors in Foodborne Bacteria. Front Microbiol. 2021 Sep 14;12:735931. doi: 10.3389/fmicb.2021.735931. eCollection 2021. [PubMed:34594318 ]
- Pecio L, Alilou M, Kozachok S, Orhan IE, Eren G, Senol Deniz FS, Stuppner H, Oleszek W: Absolute configuration of spiro-flavostilbenoids from Yucca schidigera Roezl ex Ortgies: First indication of (2R)-naringenin as the key building block. Phytochemistry. 2023 Mar;207:113584. doi: 10.1016/j.phytochem.2022.113584. Epub 2023 Jan 2. [PubMed:36603655 ]
|
---|